PENINSULA PHARMACEUTICALS
Peninsula Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the licensing, development, and commercialization anti-infective therapies for the treatment of patients with life-threatening infections for the North American and European markets. Peninsula's lead product candidate, doripenem, is a broad-spectrum antibiotic and a new member of the carbapenem class of beta-lactam antibiotics. Peninsula is currently evaluating doripenem in six Phase III clinical trials. In a... ddition, doripenem received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of nosocomial pneumonia, including ventilator-associated pneumonia (VAP). Peninsula Pharmaceuticals was acquired by Johnson & Johnson, a global manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. Peninsula Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on developing and commercializing antibiotics to treat life-threatening infections.
PENINSULA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Medical
Founded:
2001-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.peninsulapharm.com
Total Employee:
11+
Status:
Closed
Contact:
(510) 494-2900
Email Addresses:
[email protected]
Total Funding:
80 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Barrier Therapeutics
Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
Shionogi
Shionogi investment in Series C - Peninsula Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Peninsula Pharmaceuticals
Canaan Partners
Canaan Partners investment in Series C - Peninsula Pharmaceuticals
Domain Associates
Domain Associates investment in Series C - Peninsula Pharmaceuticals
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series C - Peninsula Pharmaceuticals
Montreux Equity Partners
Montreux Equity Partners investment in Series C - Peninsula Pharmaceuticals
Sears Capital Management
Sears Capital Management investment in Series B - Peninsula Pharmaceuticals
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series B - Peninsula Pharmaceuticals
Canaan Partners
Canaan Partners investment in Series B - Peninsula Pharmaceuticals
Mitsubishi International Corporation (MIC)
Mitsubishi International Corporation (MIC) investment in Series B - Peninsula Pharmaceuticals
Official Site Inspections
http://www.peninsulapharm.com
Unable to get host informations!!!
